This week, Australia’s leading health research body released its advice on puberty blockers, saying they should be available for some young people under 18. The Queensland and the Northern Territory governments, which have already banned hospitals from prescribing them, doubled down - saying they wouldn’t be changing their stance. So, what is underpinning the medical advice in Australia, and what’s the cost of ignoring it? Today, Professor Ada Cheung on the nexus of healthcare and politics - and what it means for the people caught in the middle. If you enjoy 7am, the best way you can support us is by making a contribution at 7ampodcast.com.au/support. Socials: Stay in touch with us on Instagram Guest: University of Melbourne endocrinologist and transgender health researcher Professor Ada Cheung Photo: AAP Image/Darren England
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Speaker 1I'm Ruby Jones, and you're listening to 7am. This week, Australia's leading health research body released its advice on puberty blockers, saying they should be available for some young people under 18. The Queensland and Northern Territory governments, who have already banned hospitals from prescribing them, doubled down, saying they wouldn't be changing their stance. So what's underpinning the medical advice in Australia and what's the cost of ignoring it? Today, Professor
Speaker 1Ada Chung on the nexus of healthcare and politics and what it means for the people caught in the middle.
Speaker 2It's Friday, November 20.
Speaker 3It's Friday, November 20.
Speaker 1Ada, last year, governments in Queensland and the Northern Territory banned public hospitals from prescribing puberty blockers to people under 18. So can we begin there? Tell me about those bans and what they've actually meant in practice. So it meant that trans young people who'd started puberty and their families were suddenly told that this treatment that was recommended by their doctors was not available to them. And so at the time, I believe Queensland was caring for several hundred
Speaker 1young people with gender-related needs.
Speaker 3And this left those young people and their families with the struggle of going through a puberty that didn't necessarily match who they were. Many parents are distressed and outraged. They are lying when they say that they are concerned about the health and safety of my child because they are not. It is ideological. And I've had enough of it. Many of those pubertal changes like voice deepening or facial bone structure or height or breast development are permanent and
Speaker 3so can't be reversed. And that can be very deeply distressing for a lot of young people, trans young people who already face quite high rates of depression, anxiety, self-harm, largely because of stigma and discrimination. And so from those families, I've heard descriptions of fear, grief, not knowing what to do, a lot of distress. And so families are sort of left with only a few options. Either they travel interstate or they pay privately, which is very expensive, several thousand
Speaker 3dollars a year typically, or they go without. And so it's left a lot of people in really difficult situations.
Speaker 4Hmm.
Speaker 1And so puberty blockers, which is this class of drugs that are used to stop the body producing estrogen or testosterone, they've been used for decades. But recently the UK introduced a ban on puberty blockers and that was following something called the CAS review.
Speaker 5The landmark review is warning that children.
Speaker 1who've been seeking gender care have been let down by a lack of research saying that there was no good evidence for giving transitioning drugs.
Speaker 2The CAST review is calling for gender services for young people to match the standards of other NHS care.
Speaker 1Then last year we saw Queensland ban the medication for under 18s. The Northern Territory government followed suit. So how did that unfold?
Speaker 3So Queensland have already done two independent reviews, one before the Crucifulli government came into power. And that review found that the gender service at the Queensland Children's Hospital was doing an excellent job and they recommended reducing barriers to care and expanding that service. And then when the Christopher Lee government came into power, they commissioned a second independent review and that review was led by Professor Ruth Vine. Now, Professor Vine actually concluded similar to this new NHMRC guideline
Speaker 3that there was low certainty evidence and but that she did not recommend a blanket ban and stated in her review report that these should be available for a select group of children. But the government went ahead with this ban anyway.
Speaker 4Now, these are services that require a strong multidisciplinary team approach to ensure that not only is there no harm to those children who are being provided with it, but that they are also receiving a benefit from it.
Speaker 3And so the federal government, the health minister asked NHMRC to develop national guidelines for the care of trans and gender diverse young people. So NHMRC did a rigorous independent review of the evidence and concluded that the benefits outweigh the harms and that puberty blockers should be available as an option, but decided case by case for young people, their families and their clinicians.
Speaker 6My responsibility is to make sure that that the best possible clinical care is delivered to patients. And I don't decide what that is as a non-health practitioner myself. What I do is set up the sorts of processes with an unimpeachable authority like the National Health and Medical Research Council to develop those guidelines and to provide that advice to our clinicians.
Speaker 1Let's talk a little bit more about that review because, as you say, it came back this week. It advises the use of puberty suppressants for children in certain circumstances. So tell me a bit about the questions that it was asking and what's informing that advice that we saw this week.
Speaker 3So the method of this NHMRC review is its strength. 15 studies, more than 12,000 participants, and then a multidisciplinary expert committee... weighed the evidence. And the key was that lived experience was actually built in. So that meant that the committee included trans young people, people who'd been through the process. It included parents who'd supported them. It included scientists from diverse backgrounds and clinicians from diverse backgrounds. And so they were able to work with the guideline development committee to determine what outcomes mattered. and what outcomes were critical,
Speaker 3such as pubertal development. There was moderate to high certainty evidence that puberty blockers work to block puberty, which is the whole goal. The puberty blockers are not there to cause an irreversible gender transition. The puberty blockers are there to pause puberty, to give time for the young person and their family to make a further decision, and time for that young person to mature. The committee found that the benefits outweigh the harms and that it should be available for a select group conditionally for young people who've
Speaker 3started puberty, who meet international World Health Organization ICD-11 criteria for gender incongruence and have been through a thorough assessment by a multidisciplinary teams on medical and a mental health assessment and that they've been through shared decision making with their clinician, all of their family and that there's ongoing monitoring. So Australia's advice is not out on a limb. Two-thirds of EU countries still allow access to some sort of puberty blockers. So it's an evidence-based position that sits squarely
Speaker 3within international practice and places trans young people and their families at the heart of the decision.
Speaker 1And you mentioned low certainty evidence in relation to these new guidelines. What exactly does that mean?
Speaker 3So low certainty evidence doesn't mean that there's no evidence. It means that the magnitude of that evidence is less clear. So high certainty evidence is based on randomized controlled trials. There are many areas of medicine where we don't have randomized controlled trials. It's very difficult to do a randomized controlled trial with puberty blockers because you can randomize two groups to puberty blockers or placebo, but it's very clear who's going to be going through puberty and who's not going to be going through puberty. So it's But it
Speaker 3doesn't mean there's no evidence. There have been longitudinal studies and it's the magnitude of the effect that's not clear. But if you look at just puberty suppression, right, do puberty blockers work to suppress puberty? The evidence is moderate to high.
Speaker 1Coming up, what happens when medical care is determined by your postcode? Ada, when this national advice came down this week, Queensland and the Northern Territory immediately announced that they would ignore it. They insist that they're going to maintain their bans based on their own reviews of the evidence, which I suppose begs the question, what impact does having these
Speaker 1federal guidelines really have?
Speaker 3So the national advice is that evidence-based standard of care for the sort of every clinician in the country should Governments are entitled to scrutinise advice and governments can choose not to fund a treatment, but they can't change what the evidence says. Clinicians, professional medical colleges, hospitals, insurers, courts, they all look to NHMRC guidance as the benchmark for good practice. And that matters, including for doctors in private practice in Queensland and the Northern Territory. Health services are run by states and they're entitled to do whatever they want,
Speaker 3but this guideline is already a second or even a third opinion. As I mentioned, Queensland has already commissioned two previous independent reviews. They've all come to the same conclusion. None have actually recommended a blanket ban. And so if we did another review, as Victoria has proposed, I heard the Victorian Liberal leader say that she wanted to do another review. Another review is going to look at the same studies and find the same low certainty. The or
Speaker 3on politics.
Speaker 1And we've heard some politicians, including Andrew Bragg, as well as the Federal Health Minister, Mark Butler, warn. that the health of teenagers shouldn't be kind of opened up to this public political debate.
Speaker 2Like, I think we've got to have a bit more of a better debate about these things. Like transgender people are not going to take over Australia. They're a tiny minority and we should be kind to one another. We've got to live and let live ethos in this country. I think most Australians understand that we're not all the same.
Speaker 1Are you worried that that's what we're going to see?
Speaker 3Absolutely. So we already know, I've recently published some research showing this exposure to this sort of rhetoric debate about trans people really impacts their mental health. We're talking about a tiny, tiny proportion of a marginalised population. Actually, if you look at the Royal Children's Hospital in Melbourne... They have done an audit of over 1,500 kids who've been through the gender service. Actually, only 8% ended up going through puberty blockers. The majority do not. So we're talking
Speaker 3about a very small proportion of people. That's about eight kids a year. We start many more than eight kids a year on puberty blockers for other reasons, whether that's precocious puberty or endometriosis. And so this small group of young people and the families and the doctors caring for them get caught in this crossfire of a debate that's really about politics. It's not about health. It's not about the health of the trans young person. Trans young people hear these debates and being told sort of over and over again that your existence is a problem. It adds
Speaker 3to the stigma and the minority stress that already drives poor mental health. You know, we need debate. Debate's healthy, but it needs to be a respectful consultation with you know, focused on the evidence, what the research actually shows and keeping health decisions between their clinicians, the young people, their families and their doctors.
Speaker 1And so from a healthcare perspective, what does it mean to have a system where there can be these federal guidelines, but because healthcare is state-based, very different practical options open for people based on where they happen to live?
Speaker 3Yeah, it's really unfortunate because whether a young person can get recommended care now depends on which side of the state border they live on and how much money their family has. So it's really inequitable. Families who can afford to, they would pay privately or they'd travel interstate. And families who can't, they'd go without. So those who are lower income families, they're the ones that are hit hardest. And so bans don't stop care. They push it into the private sector where there's cost thousands of dollars or they
Speaker 3move people elsewhere. And NHMRC itself has raised concerns that restricting access will push young people towards unregulated medicines or harmful strategies such as restrictive eating to stop the development of puberty. And it fragments care. And so young people lose continuity with their public health teams. It becomes harder to monitor safety and collect the data that we need. And it's also inequitable in another way. Like the same medicines remain freely available to in those jurisdictions for children
Speaker 3with precocious puberty or children with endometriosis. And so it just shows how it's really a political decision. If we are really worried about the safety of these drugs, we would be restricting them altogether, which doesn't make sense and is not based on current evidence. Healthcare should be available for everybody in Australia. Everybody should be able to access healthcare equitably.
Speaker 1Well, Ada, thank you so much for speaking with me.
Speaker 5Pleasure. Also in the news, Australia's unemployment rate has jumped to 4.9%, its highest level since 2021. New figures from the Australian Bureau of Statistics showed nearly 18,000 more Australians were unemployed in October. The sharper-than-expected rise has raised questions
Speaker 5about the Reserve Bank's recent interest rate hikes, with economists now predicting rates will remain on hold at its December meetings. And Australian Test captain Pat Cummins is standing by his denial that he knew about the 2018 ball tampering scandal after Cameron Bancroft claimed the entire team was aware of the use of sandpaper. Bancroft has admitted withholding information during Cricket Australia's original investigation, saying he wanted to protect others. Cricket Australia has announced a forum for players and staff to share their accounts, but has ruled out reopening the investigation.
Speaker 5I'm Daniel James. You've been listening to 7am. We'll be back tomorrow. you
At COP31 in Türkiye, Australia has been helping lead global negotiations over the future of fossil fuels and the fight against climate change. But while the Albanese government pushes for stronger international action,...
Anthony Albanese runs a notoriously tight ship. Across his two terms as prime minister, there’s been very little leaking, very little sniping, and very few of his Labor Party colleagues willing to speak out against him....
In 1945, in the Crimean city of Yalta, three global superpowers - America, Great Britain and the Soviet Union - met to carve up the world between them, each claiming their own sphere of influence in the final year of...
Last week it was Qantas, last month it was NAB: two giants of Australian business cutting jobs due to the growth of AI. The explanations were familiar. Qantas says it will allow the airline to unlock innovation faster...
Two weeks after Donald Trump and the Republican party were handed a drubbing of historic proportions, the world is still unpacking what the midterm results mean for the US, Trump, and the rest of the world. Few are...